Policy / Pricing FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development FDASince publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternativesPolicy / PricingRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) FDA Since publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternatives Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: 221: An Interview With Dutch Neurologist Ewout Groen of SMA EuropeNext: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
